cvot tirzepatide Long-awaited SURPASS-CVOT: Cardiovascular Outcomes with vs Dulaglutide in NEJM: #tirzepatide noninferior to #dulaglutide for 3-point MACE in T2D with ASCVD, with greater improvements in weight, A1c, BP, triglycerides, and kidney function Post hoc analysis of SURPASS-CVOT

the term in medical vocabulary refers only to opioids

we believe in empowering the research community with the knowledge to use them effectively

Ma, S., Suchomel, J., Yanez, E., Yost, E., Liang, X., Zhu, R., et al

LiJTangXTuXJinZDongHYangQet al

This event will trigger a 70% price collapse, transitioning Semaglutide from an elite luxury to a mass-market staple

Contact your doctor immediately or seek medical attention if you experience: Maculopapular rash Pruritis Liver problems Signs of high blood sugar, such as confusion, feeling sleepy, unusual thirst or hunger, urinating more often than usual, flushing, fast breathing, or breath that has a fruity odor You may experience side effects not listed